Avadel pharmaceuticals to present at the oppenheimer 32nd annual healthcare conference

Dublin, ireland, march 10, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, announced today that greg divis, chief executive officer of avadel, will participate in participate in a virtual fireside chat at the oppenheimer 32nd annual healthcare conference on thursday, march 17 at 10:40 a.m. et.
AVDL Ratings Summary
AVDL Quant Ranking